Awarded Grants

The ODC offers over 50 grant opportunities in 30+ disease areas annually to researchers across the globe, as well as within the Penn and CHOP communities. Since 2011, our grant programs have funded $17.2 million in rare disease research.

See below for a complete list of ODC-awarded grants since 2011. 

Full list of CDKL5 Program of Excellence Awardees

Awarded Grants

Displaying Results 11 - 20 of 175

Awardee Project Title Institution Grant Amount Funding Year
Yair Anikster, MD, PhD Correction of splice mutations in Ataxia-Telangiectasia through novel antisense oligonucleotides Edmond and Lily Safra Children's Hospital - Sheba Medical Center MDBR - Ataxia-Telangiectasia $65,689 2018
Hong Zhang, PhD Mechanistic study of WDR45 in the autophagy pathway and neurodegeneration University of Massachusetts Medical School MDBR - BPAN- A Neurodegeneration with Brain Iron Accumulation Disorder $50,507 2018
Delia Talos, MD The neuropathology of CDKL5 disorder University of Pennsylvania School of Medicine MDBR - CDKL5 $51,560 2018
Robert Ohgami, MD A longitudinal single cell genomic analysis of HHV8-negative multicentric Castleman Disease Stanford University MDBR - Castleman Disease $42,508 2018
Maurizio Giustetto, PhD Neuronal determinants of CDKL5 deficiency disorder: neuropathological, genetic and molecular analysis of postmortem brains University of Torino MDBR - CDKL5 $51,560 2018
Robert Waymouth, PhD A New Concept for Gene Delivery and Therapy in Cystic Fibrosis Stanford University MDBR - Nonsense Mutations in Cystic Fibrosis $52,985 2018
Diva De Leon-Crutchlow, MD, MSCE Bihormonal Bionic Pancreas for the Treatment of Diabetes Post-Pancreatectomy in Individuals with Congenital Hyperinsulinism – A Pilot Study University of Pennsylvania/Children's Hospital of Philadelphia MDBR - Congenital Hyperinsulinism $87,109 2018
Alessandra Recchia, PhD CRISPR/Cas9 nuclease design to target allele-specific Collagen VI mutations in patients' fibroblasts University of Modena and Reggio Emilia MDBR - Congenital Muscular Dystrophy $41,831 2018
Toby Hurd, PhD Functional dissection of CRB1 homophilic interactions in Retinitis pigmentosa University of Edinburgh MDBR - CRB1 degenerative retinal disease $50,497 2018
F. Brad Johnson, MD, PhD Pharmacologic rescue of telomere defects in dyskeratosis congenita University of Pennsylvania MDBR - Dyskeratosis Congenita & Telomere Biology Disorder $48,191 2018
Previous
1 2 3 4 5 6 18
Next